您的购物车当前为空
Ketoconazole (R-41400) 是一种具有广谱抗真菌活性的咪唑类(imidazole)抗真菌药物,主要通过抑制真菌细胞膜中麦角固醇(ergosterol)的生物合成发挥作用。Ketoconazole 通过抑制真菌细胞色素 P450 依赖酶 lanosterol 14α-脱甲基酶(CYP51),阻断 lanosterol 向 ergosterol 的转化,导致细胞膜结构与通透性受损,从而抑制真菌生长并产生抗真菌作用。此外,Ketoconazole 也是一种非选择性细胞色素 P450(CYP)抑制剂,尤其可抑制人类 CYP3A4 等药物代谢酶。在内分泌方面,Ketoconazole 还可抑制多种类固醇合成相关酶( CYP17A1、CYP11A1)。
别名 酮康唑, Xolegel, R-41400, Extina, (±)-Ketoconazol
Ketoconazole (R-41400) 是一种具有广谱抗真菌活性的咪唑类(imidazole)抗真菌药物,主要通过抑制真菌细胞膜中麦角固醇(ergosterol)的生物合成发挥作用。Ketoconazole 通过抑制真菌细胞色素 P450 依赖酶 lanosterol 14α-脱甲基酶(CYP51),阻断 lanosterol 向 ergosterol 的转化,导致细胞膜结构与通透性受损,从而抑制真菌生长并产生抗真菌作用。此外,Ketoconazole 也是一种非选择性细胞色素 P450(CYP)抑制剂,尤其可抑制人类 CYP3A4 等药物代谢酶。在内分泌方面,Ketoconazole 还可抑制多种类固醇合成相关酶( CYP17A1、CYP11A1)。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 mg | ¥ 298 | 现货 | |
| 100 mg | ¥ 418 | 现货 | |
| 500 mg | ¥ 655 | 现货 | |
| 1 g | ¥ 832 | 现货 | |
| 5 g | ¥ 2,851 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 460 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Ketoconazole (R-41400) is an imidazole antifungal agent with broad-spectrum antifungal activity that primarily acts by inhibiting the biosynthesis of ergosterol in the fungal cell membrane. Ketoconazole inhibits the fungal cytochrome P450-dependent enzyme lanosterol 14α-demethylase (CYP51), thereby blocking the conversion of lanosterol to ergosterol. This leads to damage to the cell membrane structure and permeability, consequently inhibiting fungal growth and producing an antifungal effect. In addition, ketoconazole is a non-selective cytochrome P450 (CYP) inhibitor, specifically inhibiting drug-metabolizing enzymes such as human CYP3A4. In terms of endocrinology, ketoconazole also inhibits various enzymes involved in steroid synthesis (CYP17A1, CYP11A1). |
| 靶点活性 | Testosterone 6β-hydroxylase:0.22 mM, Cyclosporine oxidase:0.19 mM |
| 体外活性 | 方法:人肝微粒体加入 Ketoconazole(0.3, 1, 2, 3, 5, 10 μM) 与 CYP3A 特异性底物睾酮和咪达唑仑 37°C 共孵育。高效液相色谱测定代谢产物(6β-羟基睾酮和 1'-羟基咪达唑仑)生成量。 |
| 体内活性 | 方法:将 U87-luc 细胞或患者来源的 GSC 原位接种于免疫缺陷小鼠大脑。待肿瘤形成后,随机分组开始给药。每日腹腔注射 Ketoconazole(50 mg/kg)或溶剂对照,连续治疗 4 周。通过生物发光成像监测肿瘤生长,并记录小鼠生存期。 |
| 激酶实验 | Whole Cell [3H]R1881 Binding Assay: Fibroblasts are grown to confluence in five or six 150 cm2 tissue culture flasks for routine assay. This usually requires 4-6 weeks from the time of the initial seeding of the cell line. All studies are performed between passages 3-20. Two days before assay, the medium is changed to one lacking fetal calf serum. This is repeated again 24 hours before assay. Competition assays are performed with 0.5-1.0 nM [3H]R1881 and increasing amounts of the nonradioactive compounds. Binding to low affinity sites is determined in the presence of 5 × 10-7 M R1881 and is subtracted from whole cell binding of [3H]R 1881 obtained in the absence of any inhibitor to assess binding to 5 high affinity site |
| 细胞实验 | HT29-S-B6 cells (5×105) are plated in 35-mm Petri dishes. The next day, the medium is changed and effectors are added in a small volume (10-20 μL). The incubation medium is renewed every day during the experiments. The same triplicate dishes are used for cell counts, [3H]thymidine incorporation, and flow cytometry. [3H]Thymidine (0.5 μCi) is allowed to incorporate for 24 hours; at the end of incubation, cells are rinsed with 1 mL of medium, detached with 1 mL of trypsin-EDTA, and diluted (1:3) with the culture medium. An aliquot (0.5-1 mL) is used for cell count with a Coulter Counter.(Only for Reference) |
| 别名 | 酮康唑, Xolegel, R-41400, Extina, (±)-Ketoconazol |
| 分子量 | 531.43 |
| 分子式 | C26H28Cl2N4O4 |
| CAS No. | 65277-42-1 |
| Smiles | C([C@]1(O[C@@H](COC2=CC=C(C=C2)N3CCN(C(C)=O)CC3)CO1)C4=C(Cl)C=C(Cl)C=C4)N5C=CN=C5 |
| 密度 | 1.4046 g/cm3 (Estimated) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (47.04 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 0.53 mg/mL (1 mM), Solution. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多